New Zealand markets closed

MRNA Jan 2023 240.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.4500-0.6000 (-14.81%)
As of 03:42PM EDT. Market open.
Full screen
Previous close4.0500
Open4.0000
Bid3.3500
Ask3.5500
Strike240.00
Expiry date2023-01-20
Day's range3.4500 - 4.0000
Contract rangeN/A
Volume5
Open interest2.01k
  • Motley Fool

    Why Moderna Was Sinking This Week

    The biotech's shares had lost nearly 15% of their value week to date as of mid-afternoon Friday, according to S&P Global Market Intelligence. On Thursday, The Wall Street Journal published an article stating that the government is planning to end its financial support for coronavirus vaccines and COVID-19 treatments. Although the coronavirus is still very much with us, cases in many jurisdictions -- such as the U.S. -- have been dropping, at times precipitously.

  • Motley Fool

    Why Moderna Stock Was Wilting on Wednesday

    Is star coronavirus stock Moderna (NASDAQ: MRNA) beginning a new phase of its late-pandemic life? This might have been a concern of investors after the company announced Wednesday morning that David Meline, who has served as CFO since nearly the start of the pandemic, is stepping down from the company. After all, Meline guided Moderna to a series of impressive quarterly beats on the back of the successful coronavirus vaccine the company developed and brought to market.

  • Yahoo Finance

    U.S. to end purchase of COVID-19 vaccines as industry pivots to commercial market

    Vaccines, treatments and tests will soon all be commercially available. But what that means for consumers' out-of-pocket costs is unclear.